Bionano Genomics (NASDAQ:BNGO) is preparing to release its quarterly earnings on Wednesday, 2025-05-14. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the pricing of (i) $45.0 million aggregate principal amount of senior secured convertible notes due ...

Today, we circle back on an interesting diagnostic concern called Bionano Genomics, Inc. The company continues to build out its promising optical genome mapping capabilities. However, Bionano is also ...

Bionano Genomics BNGO is set to give its latest quarterly earnings report on Thursday, 2025-08-14. Here's what investors need to know before the announcement. Analysts estimate that Bionano Genomics ...

Bionano Genomics, a company that develops technology for cancer research and diagnosis, is burning through cash at an unsustainable rate, despite its high revenue growth. The company's total ...

Bionano Genomics (NASDAQ:BNGO) will release its quarterly earnings report on Wednesday, 2024-11-13. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Bionano ...

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and ...

Fintel reports that on April 9, 2025, HC Wainwright & Co. initiated coverage of Bionano Genomics (NasdaqCM:BNGO) with a Buy recommendation. Analyst Price Forecast Suggests 2,062.54% Upside As of April ...

SAN DIEGO - Bionano Genomics, Inc. (NASDAQ:BNGO), a genome analysis solutions provider, has announced a registered direct offering resulting in the sale of over 17 million shares at $0.571 each, with ...

CEO Robert Erik Holmlin described the second quarter of 2025 as “solid,” emphasizing the positive effects of the strategic shift made in September 2024, which prioritized supporting routine users of ...